Latest Content

The National Ovarian Cancer Coalition (NOCC) delivers free meals to ovarian cancer patients, easing treatment burdens and supporting caregivers nationwide.

Immunotherapy boosts the immune system to fight cancer but may cause skin side effects; early reporting helps manage symptoms and keep treatment on track.

Researchers identified gut microbiome markers that predict melanoma return after surgery, allowing doctors to personalize immunotherapy for patients.

Caroline Taylor discusses how disparities in access and resources affect diagnosis, treatment, and survival for patients globally.

Rezetapopt showed a 44.4% response rate and durable responses over 8 months in ovarian cancer with p53 Y220C mutation, with mostly mild side effects.

A colon cancer survivor shares how practicing daily gratitude and journaling helped her find peace, healing and the strength to build a vibrant life.

Dietitian Stephanie Meyers shared practical strategies at the LiveLung SCLC Patient Summit to help patients manage appetite loss and digestive issues.

Dr. Thomas Flaig discusses new therapies, biomarkers and evolving care strategies in an interview with CURE.

After a sudden collapse, a resilient cancer survivor faces a new health crisis. Through faith, PT and grit, she overcomes despair to walk again.

The phase 3 LITESPARK-012 trial did not improve survival in advanced kidney cancer, highlighting ongoing need for better first-line treatments.

At NCCN 2026, Dr. Charles Peyton emphasized patient engagement and shared decision-making as expanding treatment options reshape bladder cancer care.

Dr. Maryam Lustberg discusses the REVITALIZE trial testing CO2 laser therapy to treat vaginal dryness and GSM in breast cancer survivors.

A tribute to Erin Cummings, a pillar of the Hodgkin lymphome survivor community who mentored others with the wisdom and grace of a real-life Mr. Miyagi.